Stocks Under Scanner in the Medical Equipment Space -- K2M Group, Masimo, NuVasive, and Prestige Brands

Thursday, October 26, 2017 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, October 26, 2017 /PRNewswire/ --

If you want a Stock Review on KTWO, MASI, NUVA, or PBH then come over

to and sign up for your free customized report. On Wednesday, October 25, 2017, the NASDAQ Composite ended the trading session at 6,563.89, down 0.52%; the Dow Jones Industrial
Average edged 0.48% lower, to finish at 23,329.46; and the S&P 500 closed at 2,557.15, slightly dropping 0.47%. Losses were broad based as all sectors ended the day in negative. This Thursday, has initiated reports coverage on the following Medical Appliances & Equipment equities: K2M Group Holdings Inc. (NASDAQ: KTWO), Masimo Corp. (NASDAQ: MASI), NuVasive Inc. (NASDAQ: NUVA), and Prestige Brands Holdings Inc. (NYSE: PBH). Take a look at the free research reports issued today on for these stocks by signing up at:

K2M Group Holdings 

Leesburg, Virginia headquartered K2M Group Holdings Inc.'s stock finished Wednesday's session 0.45% lower at $19.76 with a total trading volume of 272,241 shares. The Company's shares have advanced 5.44% over the past twelve months. The stock is trading below its 50-day moving average by 8.68%. Additionally, shares of K2M Group, which focuses on designing, developing, and commercializing spine and minimally invasive solutions in the US and internationally, have a Relative Strength Index (RSI) of 43.40.

On October 09th, 2017, research firm Needham reiterated its 'Strong Buy' rating on the Company's stock with a decrease of the target price from $29 a share to $27 a share. Sign up and read the free research report on KTWO at:


On Wednesday, shares in Irvine, California headquartered Masimo Corp. recorded a trading volume of 298,475 shares. The stock ended the session 0.63% lower at $86.59. The Company's shares have advanced 47.81% over the last twelve months and 28.47% on an YTD basis. The stock is trading above its 50-day moving average by 1.21%. Moreover, shares of Masimo, which develops, manufactures, and markets noninvasive monitoring technologies worldwide, have an RSI of 54.84. The complimentary research report on MASI can be downloaded at:


San Diego, California headquartered NuVasive Inc.'s shares closed the day 8.37% higher at $59.16. The stock recorded a trading volume of 4.34 million shares, which was above its three months average volume of 1.43 million shares. The Company's shares have gained 7.37% in the last month. The stock is trading above its 50-day moving average by 2.02%. Additionally, shares of NuVasive, which develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery, have an RSI of 63.25.

On October 25th, 2017, research firm Canaccord Genuity reiterated its 'Buy' rating on the Company's stock with a decrease of the target price from $75 a share to $70 a share. Register for free on and access the latest report on NUVA at:

Prestige Brands Holdings 

Shares in Tarrytown, New York headquartered Prestige Brands Holdings Inc. finished 0.19% higher at $47.81. The stock recorded a trading volume of 493,058 shares, which was above its three months average volume of 440.79 thousand shares. The Company's shares have 0.53% over the last twelve months. The stock is trading below its 50-day moving average by 3.89%. Furthermore, shares of Prestige Brands, which through its subsidiaries, markets, sells, manufactures, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally, have an RSI of 40.95. Get free access to your research report on PBH at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store